Semi-Annual Consolidated Statement Of Comprehensive Income

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7328181

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
10,307,000,000 JPY
11,289,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
9,910,000,000 JPY
9,910,000,000 JPY
9,910,000,000 JPY
9,910,000,000 JPY
10,634,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
22,398,000,000 JPY
-14,688,000,000 JPY
Remeasurements of defined benefit plans, net of tax
2,357,000,000 JPY
-174,000,000 JPY
Other comprehensive income
24,755,000,000 JPY
-14,863,000,000 JPY
Comprehensive income
36,044,000,000 JPY
-4,229,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
35,851,000,000 JPY
-4,349,000,000 JPY
Comprehensive income attributable to non-controlling interests
192,000,000 JPY
120,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.